323 related articles for article (PubMed ID: 26576131)
1. Potential Therapeutic Targets in Uterine Sarcomas.
Cuppens T; Tuyaerts S; Amant F
Sarcoma; 2015; 2015():243298. PubMed ID: 26576131
[TBL] [Abstract][Full Text] [Related]
2. Uterine sarcoma part III-Targeted therapy: The Taiwan Association of Gynecology (TAG) systematic review.
Yen MS; Chen JR; Wang PH; Wen KC; Chen YJ; Ng HT;
Taiwan J Obstet Gynecol; 2016 Oct; 55(5):625-634. PubMed ID: 27751406
[TBL] [Abstract][Full Text] [Related]
3. Uterine sarcoma Part II-Uterine endometrial stromal sarcoma: The TAG systematic review.
Horng HC; Wen KC; Wang PH; Chen YJ; Yen MS; Ng HT;
Taiwan J Obstet Gynecol; 2016 Aug; 55(4):472-9. PubMed ID: 27590366
[TBL] [Abstract][Full Text] [Related]
4. Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative.
Cuppens T; Annibali D; Coosemans A; Trovik J; Ter Haar N; Colas E; Garcia-Jimenez A; Van de Vijver K; Kruitwagen RP; Brinkhuis M; Zikan M; Dundr P; Huvila J; Carpén O; Haybaeck J; Moinfar F; Salvesen HB; Stukan M; Mestdagh C; Zweemer RP; Massuger LF; Mallmann MR; Wardelmann E; Mints M; Verbist G; Thomas D; Gommé E; Hermans E; Moerman P; Bosse T; Amant F
Clin Cancer Res; 2017 Mar; 23(5):1274-1285. PubMed ID: 28232476
[No Abstract] [Full Text] [Related]
5. Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.
Cotzia P; Benayed R; Mullaney K; Oliva E; Felix A; Ferreira J; Soslow RA; Antonescu CR; Ladanyi M; Chiang S
Am J Surg Pathol; 2019 May; 43(5):662-669. PubMed ID: 30789359
[TBL] [Abstract][Full Text] [Related]
6. Clinical management of uterine sarcomas.
Amant F; Coosemans A; Debiec-Rychter M; Timmerman D; Vergote I
Lancet Oncol; 2009 Dec; 10(12):1188-98. PubMed ID: 19959075
[TBL] [Abstract][Full Text] [Related]
7. BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas.
Mariño-Enriquez A; Lauria A; Przybyl J; Ng TL; Kowalewska M; Debiec-Rychter M; Ganesan R; Sumathi V; George S; McCluggage WG; Nucci MR; Lee CH; Fletcher JA
Am J Surg Pathol; 2018 Mar; 42(3):335-341. PubMed ID: 29200103
[TBL] [Abstract][Full Text] [Related]
8. PDGFR-alpha as a potential therapeutic target in uterine sarcomas.
Adams SF; Hickson JA; Hutto JY; Montag AG; Lengyel E; Yamada SD
Gynecol Oncol; 2007 Mar; 104(3):524-8. PubMed ID: 17049587
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy and hormone therapy for uterine sarcomas].
Yamashita H; Arai H; Aoki D
Gan To Kagaku Ryoho; 2012 May; 39(5):722-5. PubMed ID: 22584323
[TBL] [Abstract][Full Text] [Related]
10. [Mesenchymal and mixed uterine tumors : Current overview and practical aspects].
Lax SF
Pathologe; 2019 Feb; 40(1):36-45. PubMed ID: 30694356
[TBL] [Abstract][Full Text] [Related]
11. New Insights into Hormonal Therapies in Uterine Sarcomas.
Maccaroni E; Lunerti V; Agostinelli V; Giampieri R; Zepponi L; Pagliacci A; Berardi R
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205669
[TBL] [Abstract][Full Text] [Related]
12. The treatment of uterine sarcomas.
Reichardt P
Ann Oncol; 2012 Sep; 23 Suppl 10():x151-7. PubMed ID: 22987952
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and surgical therapy of uterine sarcoma.
Vrzic-Petronijevic S; Likic-Ladjevic I; Petronijevic M; Argirovic R; Ladjevic N
Acta Chir Iugosl; 2006; 53(3):67-72. PubMed ID: 17338203
[TBL] [Abstract][Full Text] [Related]
14. Systemic treatment in adult uterine sarcomas.
Desar IME; Ottevanger PB; Benson C; van der Graaf WTA
Crit Rev Oncol Hematol; 2018 Feb; 122():10-20. PubMed ID: 29458779
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcoma.
Dewaele B; Przybyl J; Quattrone A; Finalet Ferreiro J; Vanspauwen V; Geerdens E; Gianfelici V; Kalender Z; Wozniak A; Moerman P; Sciot R; Croce S; Amant F; Vandenberghe P; Cools J; Debiec-Rychter M
Int J Cancer; 2014 Mar; 134(5):1112-22. PubMed ID: 23959973
[TBL] [Abstract][Full Text] [Related]
16. Hormonal therapies in uterine sarcomas, aggressive angiomyxoma, and desmoid-type fibromatosis.
Pannier D; Cordoba A; Ryckewaert T; Robin YM; Penel N
Crit Rev Oncol Hematol; 2019 Nov; 143():62-66. PubMed ID: 31494310
[TBL] [Abstract][Full Text] [Related]
17. The management of patients with uterine sarcoma: a debated clinical challenge.
Gadducci A; Cosio S; Romanini A; Genazzani AR
Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
[TBL] [Abstract][Full Text] [Related]
18. Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation.
Yilmaz A; Rush DS; Soslow RA
Am J Surg Pathol; 2002 Sep; 26(9):1142-50. PubMed ID: 12218570
[TBL] [Abstract][Full Text] [Related]
19. Uterine sarcomas: histology and its implications on therapy.
Hensley ML
Am Soc Clin Oncol Educ Book; 2012; ():356-61. PubMed ID: 24451763
[TBL] [Abstract][Full Text] [Related]
20. Current status of the adjuvant therapy in uterine sarcoma: A literature review.
Rizzo A; Pantaleo MA; Saponara M; Nannini M
World J Clin Cases; 2019 Jul; 7(14):1753-1763. PubMed ID: 31417921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
